Sofinnova Partners SAS - 15 Aug 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Reporting relationship: 10%+ Owner
Issuer ticker: N/A
Reported as of: 15 Aug 2022
Net transaction value: +$3,999,990
SEC form: 4
Accepted by SEC: 17 Aug 2022, 16:19:11 UTC
Prior SEC filing: 13 Jan 2022
Source filing: View source filing
Reporting owner signature: Sofinnova Partners SAS, By /s/ Monique Saulnier, Managing Partner

Key filing fact

Sofinnova Partners SAS filed Form 4 for CinCor Pharma, Inc. on 17 Aug 2022.

Key facts

This page summarizes Sofinnova Partners SAS's Form 4 filing for CinCor Pharma, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2022, 16:19.

Change

Previous filing in this sequence was filed on 13 Jan 2022.
Current net transaction value: +$3,999,990.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CINC transaction

Common Stock

Purchase

Transaction value: $3,999,990
Shares: +133,333
Change %: +3.3%
Price: $30.00
Shares after: 4,220,979
Date: 15 Aug 2022
Ownership: By Sofinnova Capital IX
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Sofinnova Partners SAS is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.